{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:56:42Z","timestamp":1773730602096,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010841","name":"Guangdong Provincial Development and Reform Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20170623012TC"],"award-info":[{"award-number":["20170623012TC"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.yebeh.2018.10.038","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T08:07:37Z","timestamp":1554710857000},"page":"198-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study"],"prefix":"10.1016","volume":"94","author":[{"given":"Wuqiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yebeh.2018.10.038_bb0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.17712\/nsj.2017.4.20170150","article-title":"A rare case of autoimmune limbic encephalitis: an uncharted territory!","volume":"22","author":"Ibrahim","year":"2017","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"issue":"2","key":"10.1016\/j.yebeh.2018.10.038_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2018.10.038_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146455","article-title":"Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: a prospective observational registry study","volume":"11","author":"Byun","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.yebeh.2018.10.038_bb0020","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/epi.13929","article-title":"Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study","volume":"58","author":"Liu","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yebeh.2017.08.011","article-title":"Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis","volume":"77","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"11","key":"10.1016\/j.yebeh.2018.10.038_bb0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/01616412.2017.1351062","article-title":"Encephalitis with antibodies against the GABAB receptor: seizures as the most common presentation at admission","volume":"39","author":"Chen","year":"2017","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2018.10.038_bb0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2018.10.038_bb0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","article-title":"It's time to revise the definition of status epilepticus","volume":"40","author":"Lowenstein","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fneur.2015.00149","article-title":"Paving the way to understand autoantibody-mediated epilepsy on the molecular level","volume":"6","author":"Seebohm","year":"2015","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/epi4.12067","article-title":"Pathogenic potential of antibodies to the GABAB receptor","volume":"2","author":"Nibber","year":"2017","journal-title":"Epilepsia Open"},{"issue":"11","key":"10.1016\/j.yebeh.2018.10.038_bb0065","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.yebeh.2018.10.038_bb0070","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology"},{"issue":"Pt 7","key":"10.1016\/j.yebeh.2018.10.038_bb0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.12.041","article-title":"Clinical characterization of autoimmune LGI1 antibody limbic encephalitis","volume":"56","author":"Gao","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.eplepsyres.2010.05.009","article-title":"Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis","volume":"90","author":"Muehlebner","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2018.06.021","article-title":"Electroclinical features of seizures associated with autoimmune encephalitis","volume":"60","author":"Steriade","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2018.10.038_bb0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/00207454.2016.1220946","article-title":"Prevalence and predictors of subclinical seizures during scalp video-EEG monitoring in patients with epilepsy","volume":"127","author":"Jin","year":"2017","journal-title":"Int J Neurosci"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ccr3.843","article-title":"Reversible dementia: subclinical seizure in early-onset dementia","volume":"5","author":"Tjong","year":"2017","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1684\/epd.2014.0664","article-title":"Persistent frequent subclinical seizures and memory impairment after clinical remission in smoldering limbic encephalitis","volume":"16","author":"Kanazawa","year":"2014","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.12.004","article-title":"Clinical characterization of unknown\/cryptogenic status epilepticus suspected as encephalitis: a multicenter cohort study","volume":"315","author":"Shin","year":"2018","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1550059415595907","article-title":"Are there any specific EEG findings in autoimmune epilepsies?","volume":"47","author":"Baysal-Kirac","year":"2016","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2018.04.007","article-title":"Predictive values and specificity of electroencephalographic findings in autoimmune encephalitis diagnosis","volume":"84","author":"Limotai","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2018.10.038_bb0130","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1212\/NXI.0000000000000353","article-title":"Antiepileptic drug therapy in patients with autoimmune epilepsy","volume":"4","author":"Feyissa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yebeh.2014.07.018","article-title":"Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephalitis","volume":"39","author":"Sarkis","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0035-1552625","article-title":"Autoimmune epilepsy","volume":"35","author":"Toledano","year":"2015","journal-title":"Semin Neurol"},{"issue":"12","key":"10.1016\/j.yebeh.2018.10.038_bb0145","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2018.10.038_bb0150","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","article-title":"Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series","volume":"86","author":"Dogan Onugoren","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.yebeh.2018.10.038_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3174\/ajnr.A3633","article-title":"MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis","volume":"35","author":"Kotsenas","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.yebeh.2018.10.038_bb0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2018.10.038_bb0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.05.004","article-title":"Efficacy of antiepileptic drugs in autoimmune epilepsy: a systematic review","volume":"59","author":"Cabezudo-Garcia","year":"2018","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.yebeh.2018.10.038_bb0170","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00415-016-8277-y","article-title":"Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study","volume":"263","author":"Heine","year":"2016","journal-title":"J Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018307248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018307248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:28:49Z","timestamp":1761503329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505018307248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":34,"alternative-id":["S1525505018307248"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.10.038","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}